PD-L1 is a negative co-stimulatory molecule that is expressed in many cancers, where it is believed to contribute to the escape of tumors from immune recognition through binding to its receptor, PD-1, on tumor-specific T cells [38]. The gene discussed is CD274; the disease is cancer.